Clinical
‘You did nothing but claim credit’
A senior official from the Pharmacy Guild of Australia believes the Pharmaceutical Society of Australia (PSA) is claiming undue credit in relation to the NSW prescribing pilot Gerard Benedet, …
Ozempic shortages behind diabetes patients’ funeral fundraiser
Ongoing global shortages of diabetes medication, Ozempic (semaglutide), due to off-label prescribing has prompted one patient to start a GoFundMe campaign for his funeral. Diabetes patient, Stephen Callaghan, is …
British pharmacist prescribers dismiss Aussie GP’s jibe
Victorian GP, Dr Shiraz Mahkri’s claims that pharmacist prescribing in Australia will create a two-tier health system are being rubbished by British pharmacists. The Royal Australian College of General Practitioners …
Room for improvement in ADR reporting
Australia needs to adopt a robust and standardised pharmacovigilance system to improve adverse drug reaction reporting, researchers believe. A review of reporting, monitoring and handling of ADRs in Australia, published …
Pharmacist vaccination gives evidence to back prescribing role
Successful community pharmacy-based vaccination programs should be used as evidence of pharmacists’ competencies to prescribe Schedule 4 medications, Pharmaceutical Society of Australia (PSA) National President, Dr Fei Sim, believes. Addressing …
Pharmacists boost sepsis response in ED
Including emergency medicine pharmacists in the management of patients with sepsis in hospital emergency departments (EDs) delivers improved outcomes, research from Alfred Health reveals. The study, published in Emergency …
Multidisciplinary approach to fall prevention needed
Implementing fall prevention services through community pharmacies can help reduce patients’ risk of falls through pharmacist-led medication reviews and lifestyle recommendations, a study reveals. As part of a trial …
Employment status impacts severe asthma expenditure
Poorly controlled asthma is placing a substantial economic burden on Australia’s healthcare system, a study reveals. Research published in Plos One found that the employment status of patients with severe or …
Medicines update
Let’s take a look at the monthly update of new and altered medicine listings from MIMS Australia New Products Faricimab (Vabysmo) is a humanised bispecific immunoglobulin G1 (IgG1) antibody that …
Shortages at recent low: TGA
Medicines shortages in Australia are “lower than in recent months or years”, the Therapeutic Goods Administration (TGA) reports. However, the regulator noted that “there are currently some very high-profile shortages, …
Medicines pricing makes Australia unattractive for manufacturers
Australia’s reliance on overseas manufactured medications combined with medicines pricing is fueling current supply shortages, a senior Guild official believes Speaking to ABC News, Adele Tahan, vice president of the …
A need for training
While a majority of Australian pharmacists endorse the provision of low-dose cannabis-based medicines, most lack confidence in discussing them with patients and say they need more training A new Australian …